Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ANTXR2 | P58335 | 3/20 | 0.61 |
| ▸ | PTPN1 | P18031 | 4/20 | 0.61 |
| ▸ | F11 | P03951 | 2/20 | 0.56 |
| ▸ | USP2 | O75604 | 2/20 | 0.56 |
| ▸ | CA1 | P00915 | 2/20 | 0.56 |
| ▸ | CA2 | P00918 | 2/20 | 0.56 |
| ▸ | TMPRSS2 | O15393 | 1/20 | 0.56 |
| ▸ | PDE5A | O76074 | 1/20 | 0.56 |
| ▸ | HMGCR | P04035 | 1/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.56 |
| ▸ | LCK | P06239 | 1/20 | 0.56 |
| ▸ | FYN | P06241 | 1/20 | 0.56 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.56 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.56 |
| ▸ | CA6 | P23280 | 1/20 | 0.56 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.56 |
| ▸ | MAPK3 | P27361 | 1/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.56 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.56 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2816580 | 1.00 | ANTXR2 (0.61) | ANTXR2PTPN1F11USP2CA1 | |
| SCHEMBL10177705 | 1.00 | ANTXR2 (0.61) | ANTXR2PTPN1F11USP2CA1 | |
| SCHEMBL12172394 | 1.00 | ANTXR2 (0.61) | ANTXR2PTPN1F11USP2CA1 | |
| SCHEMBL19038896 | 1.00 | ANTXR2 (0.61) | ANTXR2PTPN1F11USP2CA1 | |
| SCHEMBL1322250 | 1.00 | ANTXR2 (0.61) | ANTXR2PTPN1F11USP2CA1 | |
| SCHEMBL2814863 | 1.00 | ANTXR2 (0.61) | ANTXR2PTPN1F11USP2CA1 | |
| SCHEMBL13024918 | 0.97 | PTPN1 (0.61) | ANTXR2PTPN1F11USP2CA1 | |
| SCHEMBL3785587 | 0.95 | PTPN1 (0.67) | ANTXR2PTPN1F11USP2CA1 | |
| SCHEMBL18083458 | 0.95 | PTPN1 (0.67) | ANTXR2PTPN1F11USP2CA1 | |
| SCHEMBL19479105 | 0.95 | PTPN1 (0.67) | ANTXR2PTPN1F11USP2CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4529477-A1 | POROUS EXPANDING BIOCOMPATIBLE SCAFFOLDS | Danmarks Tekniske Universitet (DK) | 2025-04-02 | — | — | EP | claimed |
| EP-4529468-A1 | FORMULATION OF API'S AND EXCIPIENT'S IN AN ICELL VIA HYDROPHOBIC ION PAIRING | Danmarks Tekniske Universitet (DK) | 2025-04-02 | — | — | EP | claimed |
| WO-2023227517-A1 | FORMULATION OF API'S AND EXCIPIENT'S IN AN ICELL VIA HYDROPHOBIC ION PAIRING | DANMARKS TEKNISKE UNIVERSITET (DK) | 2023-11-30 | — | — | WO | claimed |
| WO-2023227518-A1 | POROUS EXPANDING BIOCOMPATIBLE SCAFFOLDS | DANMARKS TEKNISKE UNIVERSITET (DK) | 2023-11-30 | — | — | WO | claimed |
| EP-4282448-A1 | POROUS EXPANDING BIOCOMPATIBLE SCAFFOLDS | Danmarks Tekniske Universitet (DK) | 2023-11-29 | — | — | EP | claimed |
| US-20220339285-A1 | DISSACHARIDE FORMULATIONS FOR CONTROLLED DRUG RELEASE | TECHNICAL UNIVERSITY OF DENMARK (DK) | 2022-10-27 | — | — | US | claimed |
| EP-3982922-A1 | DISSACHARIDE FORMULATIONS FOR CONTROLLED DRUG RELEASE | Technical University of Denmark (DK) | 2022-04-20 | — | — | EP | claimed |
| WO-2020249801-A1 | DISSACHARIDE FORMULATIONS FOR CONTROLLED DRUG RELEASE | TECHNICAL UNIVERSITY OF DENMARK (DK) | 2020-12-17 | — | — | WO | claimed |
| US-20250332283-A1 | NUCLEOTIDE DELIVERY FROM INJECTABLE HYDROPHOBIC BIOMATERIAL | UNIV DANMARKS TEKNISKE (DK) | 2025-10-30 | — | — | US | disclosed |
| WO-2025108545-A1 | DELIVERY OF NUCLEOTIDES FROM INJECTABLE BIOMATERIAL | DANMARKS TEKNISKE UNIVERSITET (DK) | 2025-05-30 | — | — | WO | disclosed |
| EP-4529477-A1 | POROUS EXPANDING BIOCOMPATIBLE SCAFFOLDS | Danmarks Tekniske Universitet (DK) | 2025-04-02 | — | — | EP | disclosed |
| EP-4529453-A1 | NUCLEOTIDE DELIVERY FROM INJECTABLE HYDROPHOBIC BIOMATERIAL | Danmarks Tekniske Universitet (DK) | 2025-04-02 | — | — | EP | disclosed |
| EP-4529468-A1 | FORMULATION OF API'S AND EXCIPIENT'S IN AN ICELL VIA HYDROPHOBIC ION PAIRING | Danmarks Tekniske Universitet (DK) | 2025-04-02 | — | — | EP | disclosed |
| WO-2023227548-A1 | NUCLEOTIDE DELIVERY FROM INJECTABLE HYDROPHOBIC BIOMATERIAL | DANMARKS TEKNISKE UNIVERSITET (DK) | 2023-11-30 | — | — | WO | disclosed |
| WO-2020249801-A1 | DISSACHARIDE FORMULATIONS FOR CONTROLLED DRUG RELEASE | TECHNICAL UNIVERSITY OF DENMARK (DK) | 2020-12-17 | — | — | WO | disclosed |
| WO-2020249801-A1 | DISSACHARIDE FORMULATIONS FOR CONTROLLED DRUG RELEASE | TECHNICAL UNIVERSITY OF DENMARK (DK) | 2020-12-17 | — | — | WO | disclosed |
| WO-2019243422-A1 | SOLUTION COMPRISING FLUORESCENT DYE AS FIDUCIAL MARKER | DANMARKS TEKNISKE UNIVERSITET (DK) | 2019-12-26 | — | — | WO | disclosed |
| WO-2019243419-A1 | BRACHYGEL FOR TREATMENT OF CANCER AND/OR FOR GUIDANCE OF SURGERY | DANMARKS TEKNISKE UNIVERSITET (DK) | 2019-12-26 | — | — | WO | disclosed |
| US-5492836-A | PERBENZOYLATION; CLEAVAGE BY CONTACTING WITH BROMOACETYL BROMIDE/WATER; GLYCOSIDATION; METHOXYCINNAMOYLATION; ANALYZING RESULTING BENZOATES | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 1996-02-20 | — | — | US | disclosed |
| WO-1991007649-A1 | METHOD FOR DETERMINING THE STRUCTURE OF OLIGOSACCHARIDE LINKAGES AND AUTOMATED INSTRUMENTATION THEREFOR | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 1991-05-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250332283-A1 | NUCLEOTIDE DELIVERY FROM INJECTABLE HYDROPHOBIC BIOMATERIAL | SLC29A1, SLC29A2, SLC43A3 | ANTXR2 2211/4885PTPN1 4254/4885F11 4666/4885 |
| US-20220339285-A1 | DISSACHARIDE FORMULATIONS FOR CONTROLLED DRUG RELEASE | LIPA, LIPE, CEL | ANTXR2 4670/4885PTPN1 1229/4885F11 2692/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.